Kourtney Kardashian Barker's supplement brand, Lemme, launched in September 2022, has faced a significant backlash over several of its products, most notably an "Ozempic-style" weight-loss supplement. Kourtney, known as the most health-conscious of the Kardashian sisters, founded Lemme after becoming acutely aware of the importance of what we put into our bodies, a realization sparked by the birth of her eldest son, Mason.

The latest product to draw widespread criticism is Lemme GLP-1 Daily, an "Ozempic-style" weight-loss supplement. This pill directly references the GLP-1 hormone, which is naturally released by the body after eating. Ozempic, originally a diabetes medicine, gained popularity as a weight-loss aid in 2022, utilizing a synthetic version of the GLP-1 hormone as a weekly jab to slow digestion, dull hunger, and aid in weight loss. While Lemme's new pill claims to naturally increase GLP-1 levels over time using lemon and saffron extracts, it explicitly does not contain the key ingredients found in pharmaceutical Ozempic. Despite this, the brand marketed it as "a GLP-1 solution without the side effects," with Kourtney herself promoting an article discussing her desire to be "in on the Ozempic boom."

The product, priced at an eye-watering £69 for a one-time purchase (30 servings) or £55.23 for a monthly subscription, has been heavily scrutinized by both fans and medical professionals. Critics accuse Kourtney of exploiting societal pressures and insecurities related to body image, particularly among young women. Plastic surgeon Naveen Cavale slammed Kourtney for "cashing in" on individuals struggling with body image, believing the product to be "incredibly misleading" and potentially exacerbating mental health issues like anxiety, stress, and depression due. Cavale emphasized that while the supplement is marketed as a natural alternative, it lacks the scientifically proven impact of injectable medications like Ozempic, which contains semaglutide – a rigorously tested GLP-1 receptor.

Furthermore, experts like Cavale assert that if Lemme's pill contained actual GLP-1, it would be classified as a drug, not a supplement. He stated there is "little to no clinical evidence to support significant weight loss from these ingredients." A crucial disclaimer on Lemme's small print reveals that its claims have not been evaluated by the Food and Drug Administration (FDA), stating, "This product is not intended to diagnose, treat, cure or prevent any disease." The FDA ensures the safety, efficacy, and security of drugs, vitamins, supplements, and medical devices, with approved products undergoing thorough testing.

Beyond the GLP-1 Daily, Lemme has faced criticism for other products as well. Lemme Smooth, a daily tablet released in June, claims to reduce cellulite in just 28 days using French Cantaloupe Melon extract. However, medical experts, including Naveen Cavale, dismiss it as a "fad" with "no scientific backing." Cavale highlights that cellulite is a common, harmless, and natural skin condition, advising patients to adopt a holistic approach of balanced diet, regular exercise, and positive body image instead of relying on unproven and costly remedies. Similarly, Lemme’s vagina gummies, called Lemme Purr, marketed to boost vaginal health and alter its taste with pineapple and Vitamin C, drew sharp rebuke from gynecologist Dr. Jen Gunter. Dr. Gunter publicly stated that "Anyone who suggests that your vagina isn't fresh or needs an improved taste is a misogynist and awful person. And yes, that includes you Kourtney Kardashian and your Lemme grift," also disputing the claim that pineapples affect bodily fluid taste.

While Lemme's Sleep Gummies initially went viral on TikTok, the brand's overall trajectory has been marred by these controversies. Medical professionals consistently urge consumers to consult medical professionals for effective solutions rather than relying on unproven supplements, highlighting the potential for false hope, frustration, and worsened body image issues.